These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 27166248)

  • 1. Watchful Waiting in Continuous-Flow Left Ventricular Assist Device Patients With Ongoing Hemolysis Is Associated With an Increased Risk for Cerebrovascular Accident or Death.
    Levin AP; Saeed O; Willey JZ; Levin CJ; Fried JA; Patel SR; Sims DB; Nguyen JD; Shin JJ; Topkara VK; Colombo PC; Goldstein DJ; Naka Y; Takayama H; Uriel N; Jorde UP
    Circ Heart Fail; 2016 May; 9(5):. PubMed ID: 27166248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Durability of left ventricular assist devices: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 2006 to 2011.
    Holman WL; Naftel DC; Eckert CE; Kormos RL; Goldstein DJ; Kirklin JK
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):437-41.e1. PubMed ID: 23490245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombolysis for suspected intrapump thrombosis in patients with continuous flow centrifugal left ventricular assist device.
    Muthiah K; Robson D; Macdonald PS; Keogh AM; Kotlyar E; Granger E; Dhital K; Spratt P; Jansz P; Hayward CS
    Artif Organs; 2013 Mar; 37(3):313-8. PubMed ID: 23373528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Decade of Experience With Continuous-Flow Left Ventricular Assist Devices.
    John R; Holley CT; Eckman P; Roy SS; Cogswell R; Harvey L; Shumway S; Liao K
    Semin Thorac Cardiovasc Surg; 2016 Summer; 28(2):363-375. PubMed ID: 28043445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure.
    Uriel N; Colombo PC; Cleveland JC; Long JW; Salerno C; Goldstein DJ; Patel CB; Ewald GA; Tatooles AJ; Silvestry SC; John R; Caldeira C; Jeevanandam V; Boyle AJ; Sundareswaran KS; Sood P; Mehra MR
    Circulation; 2017 May; 135(21):2003-2012. PubMed ID: 28385948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical approach to continuous-flow left ventricular assist device explantation: A comparison of outcomes.
    Baldwin AC; Sandoval E; Letsou GV; Mallidi HR; Cohn WE; Frazier OH
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):192-8. PubMed ID: 26344685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelet Therapy and Adverse Hematologic Events During Heart Mate II Support.
    Saeed O; Shah A; Kargoli F; Madan S; Levin AP; Patel SR; Jermyn R; Guerrero C; Nguyen J; Sims DB; Shin J; D'Alessandro D; Goldstein DJ; Jorde UP
    Circ Heart Fail; 2016 Jan; 9(1):e002296. PubMed ID: 26721914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sildenafil Is Associated With Reduced Device Thrombosis and Ischemic Stroke Despite Low-Level Hemolysis on Heart Mate II Support.
    Saeed O; Rangasamy S; Selevany I; Madan S; Fertel J; Eisenberg R; Aljoudi M; Patel SR; Shin J; Sims DB; Reyes Gil M; Goldstein DJ; Slepian MJ; Billett HH; Jorde UP
    Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29092891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse events in contemporary continuous-flow left ventricular assist devices: A multi-institutional comparison shows significant differences.
    Stulak JM; Davis ME; Haglund N; Dunlay S; Cowger J; Shah P; Pagani FD; Aaronson KD; Maltais S
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):177-89. PubMed ID: 26545967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence, Management, and Outcome of Suspected Continuous-Flow Left Ventricular Assist Device Thrombosis.
    Upshaw JN; Kiernan MS; Morine KJ; Kapur NK; DeNofrio D
    ASAIO J; 2016; 62(1):33-9. PubMed ID: 26479464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemolysis: a harbinger of adverse outcome after left ventricular assist device implant.
    Cowger JA; Romano MA; Shah P; Shah N; Mehta V; Haft JW; Aaronson KD; Pagani FD
    J Heart Lung Transplant; 2014 Jan; 33(1):35-43. PubMed ID: 24418732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood pressure and adverse events during continuous flow left ventricular assist device support.
    Saeed O; Jermyn R; Kargoli F; Madan S; Mannem S; Gunda S; Nucci C; Farooqui S; Hassan S; Mclarty A; Bloom M; Zolty R; Shin J; D'Alessandro D; Goldstein DJ; Patel SR
    Circ Heart Fail; 2015 May; 8(3):551-6. PubMed ID: 25870369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of echocardiography in patients with intravascular hemolysis due to suspected continuous-flow LVAD thrombosis.
    Fine NM; Topilsky Y; Oh JK; Hasin T; Kushwaha SS; Daly RC; Joyce LD; Stulak JM; Pereira NL; Boilson BA; Clavell AL; Edwards BS; Park SJ
    JACC Cardiovasc Imaging; 2013 Nov; 6(11):1129-40. PubMed ID: 24094831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices.
    Kamdar F; John R; Eckman P; Colvin-Adams M; Shumway SJ; Liao K
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):575-81. PubMed ID: 23321132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HeartMate II Left Ventricular Assist Device Pump Exchange: A Single-Institution Experience.
    Shaikh AF; Joseph SM; Lima B; Hall SA; Malyala R; Rafael AE; Gonzalez-Stawinski GV; Chamogeorgakis T
    Thorac Cardiovasc Surg; 2017 Aug; 65(5):410-414. PubMed ID: 27903010
    [No Abstract]   [Full Text] [Related]  

  • 16. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombosis in Continuous Flow Left Ventricular Assist Devices: Our Clinical Experience With Medical and Surgical Management.
    Köksel U; Erbasan O; Bayezid Ö; Kemaloğlu C; Özçobanoğlu S; Gölbaşı I; Türkay C
    Transplant Proc; 2016; 48(6):2162-7. PubMed ID: 27569964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Argatroban as novel therapy for suspected thrombosis in patients with continuous-flow left ventricle assist device and hemolysis.
    Badiye A; Hernandez GA; Chaparro S
    ASAIO J; 2014; 60(3):361-5. PubMed ID: 24614354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced heart failure treated with continuous-flow left ventricular assist device.
    Slaughter MS; Rogers JG; Milano CA; Russell SD; Conte JV; Feldman D; Sun B; Tatooles AJ; Delgado RM; Long JW; Wozniak TC; Ghumman W; Farrar DJ; Frazier OH;
    N Engl J Med; 2009 Dec; 361(23):2241-51. PubMed ID: 19920051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is the optimal anticoagulation in patients with a left ventricular assist device?
    Rossi M; Serraino GF; Jiritano F; Renzulli A
    Interact Cardiovasc Thorac Surg; 2012 Oct; 15(4):733-40. PubMed ID: 22761118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.